4.5 million Americans living with total knee replacement

February 10, 2012 in Arthritis & Rheumatism

New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that more than 4.5 million Americans are living with a total knee replacement (TKR), as the number of TKR surgeries has more than doubled over the past decade, with the sharpest rise among younger patients. Osteoarthritis continues to be the primary reason for TKR.

Investigators used a ; U.S. Census data; information from the National , the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative; and other national data and literature to determine the number of Americans living with TKR.

The study, funded by the U.S. National Institutes of Health's National Institute of Arthritis and Musculoskeletal and , found that more than 4.5 million Americans are currently living with at least one TKR. This represents 4.7 percent of the population age 50 years or older – higher than the national rates for congestive heart failure and rheumatoid arthritis. In addition:

  • The prevalence of is higher in women and so is TKR: 5.3 percent, compared to 4.1 percent in men.
  • Among persons age 60 to 69, 4.1 percent of men and 4.8 percent of women have a TKR; among those ages 70 to 79, 7.1 percent of men and 8.2 percent of women have had at least one knee replaced.
  • Ten percent of Americans age 80 and older are living with a TKR.
"The number of total knee replacements is growing drastically," said Elena Losina, PhD, lead investigator and co-director of Orthopedic and Arthritis Center for Outcomes Research at Brigham and Women's Hospital in Boston, Mass. "We now have a lot of people living with TKR," which may lead to substantial increases in the likelihood of revisions and complications, especially in younger patients.

The findings may aide in anticipating the future challenges related to TKR, including capacity for follow-up care, health care costs, and treatment access.

Provided by American Academy of Orthopaedic Surgeons search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Did a 16 year old solve a centuries-old problem by Newton?
    created2 hours ago
  • Theoretical highest electric charge?
    created5 hours ago
  • Effect of Damping wave on vibration
    created5 hours ago
  • How does impulse relate to energy when the net force is zero?
    created5 hours ago
  • Calculating Saturation Vapor Pressure?
    created13 hours ago
  • Question about high electric charge.
    created17 hours ago
  • More from Physics Forums - Classical Physics

More news stories

Gender, high DAS28-P index predictive of pain in early RA

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness and visual ...

Arthritis & Rheumatism created May 18, 2012 | popularity not rated yet | comments 0

New biomarker test predicts arthritis at much earlier stage

More than 27 million adults currently suffer from osteoarthritis, which is the most common form of arthritis. In the past, doctors have been unable to diagnose patients with arthritis until they begin to show symptoms, which ...

Arthritis & Rheumatism created May 15, 2012 | popularity 4 / 5 (1) | comments 0 | with audio podcast

Systemic sclerosis complications more severe in African Americans than Caucasians

African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), ...

Arthritis & Rheumatism created May 10, 2012 | popularity not rated yet | comments 0

FDA panel urges approval for Pfizer arthritis drug

An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.

Arthritis & Rheumatism created May 09, 2012 | popularity not rated yet | comments 0

Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis

Untangling the root cause of rheumatoid arthritis has been a difficult task for immunologists, as decades of research has pointed to multiple culprits in our immune system, with contradictory lines of evidence. Now, researchers ...

Arthritis & Rheumatism created May 08, 2012 | popularity not rated yet | comments 0 | with audio podcast


T cells 'hunt' parasites like animal predators seek prey, study shows

By pairing an intimate knowledge of immune-system function with a deep understanding of statistical physics, a cross-disciplinary team at the University of Pennsylvania has arrived at a surprising finding: T cells use a movement ...

Same gene that stunts infants' growth also makes them grow too big: research

UCLA geneticists have identified the mutation responsible for IMAGe* syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes ...

Almost half of new vets seek disability

(AP) -- America's newest veterans are filing for disability benefits at a historic rate, claiming to be the most medically and mentally troubled generation of former troops the nation has ever seen.

Color-changing contact lenses to help diabetics (w/ Video)

For the millions of Americans with diabetes, the inconvenient and often painful method of testing blood sugar levels is a way of life. But research and innovative product design by scientists at The University of Akron may ...

Missouri opts for untested drug for executions

(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.